Why Is Novavax (NVAX) Stock Down Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Pfizer and Moderna received FDA approval for their omicron-specific booster. NVAX stock is hitting new 52-week lows in response.
The post Why Is Novavax (NVAX) Stock Down Today? appeared first on InvestorPlace.
More From InvestorPlace